S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Seres TherapeuticsZynerba PharmaceuticalsOptiNoseSyndax PharmaceuticalsLannett
SymbolNASDAQ:MCRBNASDAQ:ZYNENASDAQ:OPTNNASDAQ:SNDXNYSE:LCI
Price Information
Current Price$3.46$8.58$7.72$6.79$11.44
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$11.60$22.00$25.00$14.00$14.00
% Upside from Price Target235.26% upside156.41% upside223.83% upside106.19% upside22.38% upside
Trade Information
Market Cap$243.30 million$193.93 million$309.14 million$178.31 million$482.85 million
Beta1.814.750.582.432.26
Average Volume404,5261,590,386193,283166,4731,611,042
Sales & Book Value
Annual Revenue$28.27 million$90,000.00$7.07 million$1.52 million$655.41 million
Price / Sales8.562,211.5445.25121.220.71
CashflowN/AN/AN/AN/A$3.59 per share
Price / CashN/AN/AN/AN/A3.19
Book Value($1.18) per share$3.27 per share$2.88 per share$2.14 per share$8.49 per share
Price / Book-2.932.622.683.171.35
Profitability
Net Income$-98,940,000.00$-39,910,000.00$-106,660,000.00$-73,960,000.00$-272,110,000.00
EPS($2.43)($2.61)($2.68)($2.92)$2.35
Trailing P/E RatioN/AN/AN/AN/A4.87
Forward P/E RatioN/AN/AN/AN/A6.85
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-198.12%N/A-670.20%-4,310.68%-41.52%
Return on Equity (ROE)N/A-52.19%-102.10%-108.44%28.00%
Return on Assets (ROA)-63.68%-46.10%-52.94%-71.24%7.35%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A1.06%0.01%1.98%
Current Ratio2.53%9.37%6.60%4.90%2.67%
Quick Ratio2.53%9.37%6.43%4.90%1.86%
Ownership Information
Institutional Ownership Percentage87.98%36.76%64.98%63.28%98.04%
Insider Ownership Percentage37.00%10.79%44.30%8.30%12.57%
Miscellaneous
Employees14525102381,020
Shares Outstanding69.91 million23.20 million41.44 million27.14 million40.41 million
Next Earnings Date11/14/2019 (Estimated)11/14/2019 (Estimated)11/12/2019 (Estimated)11/4/2019 (Estimated)11/6/2019 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
 Seres TherapeuticsZynerba PharmaceuticalsOptiNoseSyndax PharmaceuticalsLannett

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel